Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving viable micro-organism
Patent
1997-06-05
1999-11-16
Leary, Louise N.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving viable micro-organism
435 4, 435 17, 435975, 424 91, 4242771, 424 931, 424553, 424551, C12Q 102, C12Q 100, C12Q 150, G01N 3353
Patent
active
059855924
ABSTRACT:
In accordance with the present invention, it has been discovered that monocyte conditioned medium (MCM) obtained from patients with liver disease stimulates the proliferation of fibroblasts. Platelet derived growth factor (PDGF) has also been found to stimulate fibroproliferation of fibroblasts, and to be at least partially responsible for the fibroproliferative effect of the MCM. Further in accordance with the present invention, the effect of MCM and PDGF on the expression of c-fos and c-jun has been investigated, because c-fos and c-jun form AP-1 complexes which can stimulate genes involved in proliferation. It has recently been reported that pentoxifylline inhibits platelet derived growth factor-stimulated proliferation. The mechanism of this action of pentoxifylline is unclear. Thus, in the course of the work undertaken as part of the present invention, studies were conducted to determine whether pentoxifylline altered the expression of c-fos and c-jun. While PDGF was found to induce the expression of both c-fos and c-jun, pentoxifylline was found to effectively reduce the effect of PDGF-induced c-jun gene expression, without altering c-fos gene expression. These results suggest that pentoxifylline inhibits PDGF stimulated proliferation by decreasing c-jun expression. These results further suggest a variety of diseases and/or conditions which may also be successfully treated with pentoxifylline.
REFERENCES:
patent: 4160452 (1979-07-01), Theeuwes
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
patent: 5077296 (1991-12-01), Drizen
patent: 5096906 (1992-03-01), Mandell et al.
patent: 5366978 (1994-11-01), Furukawa et al.
Bamberger et al., "Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells" Proc. Natl. Acad. Sci. USA, 93:6169-6174 (1996).
Bessler et al., "Effect of Pentoxifylline on the Phagocytic Activity, cAMP Levels, and Superoxide Anion Production by Monocytes and Polymorphonuclear Cells" J. Leukocyte Biol., 40:747-754 (1986).
Bogoyevitch, et al., "Cellular Stresses Differentially Activate c-Jun N-terminal Protein Kinases and Extracellular Signal-regulated Protein Kinases in Cultured Ventricular Myocytes" J. Biol. Chem., 270(50):29710-17 (1995).
Buchdunger et al., "Inhibition of the Abl Protein-Tyrosine Kinase in Vitro and in Vivo by a 2-Phenylaminopyrimidine Derivative" Cancer Res., 56:100-4 (1996).
Burgering et al., "cAMP antagonizes p21.sup.ras -directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor" The EMBO Journal, 12(11):4211-4220 (1993).
Cimminiello et al., "Platelet-Derived Growth Factor (PDGF) in Patients with Different Degrees of Chronic Arterial Obstructive Disease" Angiology, 45(4):289-293 (1994).
Coso et al., "Transforming G Protein-coupled Receptors Potently Activate JNK (SAPK)" J. Biol. Chem., 270(10):5620-5624 (1995).
Crespo et al., "Signaling through Transforming G Protein-coupled Receptors in NIH 3T3 Cells Involves c-Raf Activation" J. Biol. Chem., 269(33):21103-21109 (1994).
Davis, "The Mitogen-activated Protein Kinase Signal Transduction Pathway" R.J. J. Biol. Chem., 268(20):14553-14556 (1993).
Dohlman et al. "Generation of a unique fibroblast-activating factor by human monocytes" Immunol., 52:577-584 (1984).
Gesualdo et al., "Platelet-Derived Growth Factor Expression in Mesangial Proliferative Glomerulonephritis" Lab Invest., 65(2):160-167 (1991).
Herschman, H. R., "Primary Response Genes Induced by Growth Factors and Tumor Promoters" Ann. Rev. of Biochem., 60:281-319 (1991).
Hunter and Karin, "the Regulation of Transcription by Phosphorylation" Cell, 70:375-387 (1992).
Lo et al., "Reactive Oxygen Species Mediate Cytokine Activation of c-Jun NH.sub.2 -terminal Kinases*" J. Biol. Chem., 271(26):15703-15707 (1996).
Leon and Rojkind, "A Simple Micromethod for Collagen and Total Protein Determination in Formalin-fixed Paraffin-embedded Sections.sup.1,2 " J. Histochem. and Cytochem., 33(8):737-743 (1985).
Luke and Rocci, "Determination of pentoxifylline and a major metabolite, 3,7-demethyl-1-(5'-hydroxyhexy)xanthine, by high-performance liquid chromatography" J. Chromatogr., 374(1):191-195 (1986).
Marra et al., "Involvement of phosphatidylinositol 3-kinase in the activation of extracellular signal-regulated kinase by PDGF in hepatic stellate cells" FEBS Lett., 376:141-145 (1995).
McCormick, F., "How receptors turn Ras on" Nature, 363:15-16 (1993).
Meskini et al., "Phosphodiesterase Inhibitory Profile of Some Related Xanthine Derivatives Pharmacologically Active on the Peripheral Microcirculation" Biochem. Pharmacol., 47(5):781-788 (1994).
Nakamura et al., "Renal Platelet-Derived Growth Factor Gene Expression in NZB/W F1 Mice with Lupus and ddY Mice with IgA Nephropathy" Clin. Immunol. Immunopathol., 63(2):173-181 (1992).
Palech, S.L., "Networking with protein kinases" Curr. Biol., 3(8):513-515 (1993).
Pesonen, E., "Infection and intimal thickening: evidence from coronary arteries in children" Eur. Heart J., 15(Suppl X):57-61 (1994).
Peterson, "Interleukin-1, platelet derived growth factor, free radicals and monocyte aryl hydrocarbon hydroxylase activity in liver disease. Role of cell communication" Biochem. Pharmacol., 43(5):1163-1166 (1992).
Peterson, T. C., "Pentoxifylline Prevents Fibrosis in an Animal Model and Inhibits Platelet-derived Growth Factor-driven Proliferation of Fibroblasts" Hepatol., 17(3):486-493 (1993).
Peterson, T.C. "Inhibition of Fibroproliferation by Pentoxifylline Activity of Metabolite-1 and Lack of Role of Adenosine Receptors" Biochem. Pharmacol., 52:597-602 (1996).
Peterson and Isbrucker, "Fibroproliferation in Liver Disease: Role of Monocyte Factors" Hepatol., 15(2):191-197 (1992).
Peterson and Neumeister, "Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism" Immunopharmacol., 31:183-193 (1996).
Peterson and Tanton, "Effect of Pentoxifylline In Collagenous Colitis" Can. J. Gastroenterol., 10:S76 (1996).
Peterson et al., "In vitro effect of platelet-derived growth factor on fibroproliferation and effect of cytokine antagonists" Immunopharmacol., 28:259-270 (1994).
Pietrogrande et al., "A Role for Platelet-Derived Growth Factor in Drug-Induced Chronic Ergotism? A Case Report" Angiology, 46(7):633-636 (1995).
Rosenwald et al., "Transient inhibition of protein synthesis induces expression of proto-oncogenes and stimulates resting cells to enter the cell cycle" Cell Prolif. 28:631-644 (1995).
Schafer et al., "PACAP Stimulates Transcription of c-Fos and c-Jun and Activates the P-1 Transcription Factor in Rat Pancreatic Carcinoma Cells" Biochem. Biophys. Res. Commun., 221:111-116 (1996).
Schlesinger, J., "How receptor tyrosine kinases activate Ras" Trends Biochem. Sci., 18:273-275 (1993).
Shaw et al., "Pathogenesis of Pulmonary Fibrosis in Interstitial Lung Disease" Am. Rev. Respir. Dis., 143:167-173 (1991).
Terano et al., "Eicosapentaenoic Acid Suppressed the Proliferation of Vascular Smooth Muscle Cells Through Modulation of Various Steps of Growth Signals" Lipids, 31:S301-S304 (1996).
Uebelhoer et al., "Modulation of Fibroblast Activity in Histiocytosis X by Platelet-Derived Growth Factor" Chest., 107:701-705 (1995).
Wu et al., "Inhibition of the EGF-Activated MAP Kinase Signaling Pathway by Adenosine 3',5'-Monophosphate" Science, 262:1065-1069 (1993).
Xie and Hershcan, "v-src Induces Prostaglandin Synthase 2 Gene Expression by Activation of the c-June N-terminal Kinase and the c-June Transcription Factor*" J. Biol. Chem., 270:27622-27628 (1995).
Zar, J.H. in Biostatistical methods. Prentice-Hall (Englewood Cliffs, N.J., 1974).
Dalhousie University
Kim Stanley H.
Leary Louise N.
Reiter Stephen E.
LandOfFree
Uses for pentoxifylline or functional derivatives/metabolites th does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Uses for pentoxifylline or functional derivatives/metabolites th, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses for pentoxifylline or functional derivatives/metabolites th will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1323181